How to buy Titan Pharmaceuticals stock (TTNP)

Titan Pharmaceuticals is a biotechnology business based in the US. Titan Pharmaceuticals shares (TTNP) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $3.95 – a decrease of 8.14% over the previous week. Titan Pharmaceuticals employs 4 staff and has a trailing 12-month revenue of around $3,000.

Our top picks for where to buy Titan Pharmaceuticals stock

Buy Titan Pharmaceuticals stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Titan Pharmaceuticals stock price (NASDAQ: TTNP)

Use our graph to track the performance of TTNP stocks over time.

Titan Pharmaceuticals shares at a glance

• Key figures

Information last updated 2024-10-24.

Latest market close	$3.95
52-week range	$3.96 - $14.80
50-day moving average more info button	$5.57
200-day moving average more info button	$6.33
Wall St. target price	$7.00
PE ratio more info button	N/A
Dividend yield more info button	N/A
Earnings per share (TTM) more info button	$-6.64

Is it a good time to buy Titan Pharmaceuticals stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Titan Pharmaceuticals price performance over time

Historical closes compared with the close of $3.8199 from 2024-10-28

1 week (2024-10-22)	-11.78%
1 month (2024-09-30)	-27.52%
3 months (2024-07-30)	-31.91%
6 months (2024-04-30)	-43.03%

1 year (2023-10-30)	788.35%
2 years (2022-10-28)	262.28%
3 years (2021-10-28)	108.74%
5 years (2019-10-30)	5.58

Titan Pharmaceuticals financials

Revenue TTM	$3,000
Gross profit TTM	$-4,365,000
Return on assets TTM	-172.63%
Return on equity TTM	-368.99%
Profit margin	0%
Book value	$4.37
Market Capitalization more info button	$3.6 million

TTM: trailing 12 months

Titan Pharmaceuticals share dividends

We're not expecting Titan Pharmaceuticals to pay a dividend over the next 12 months.

Have Titan Pharmaceuticals's shares ever split?

Titan Pharmaceuticals's shares were split on a 1:20 basis on 8 January 2024 . So if you had owned 20 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Titan Pharmaceuticals shares – just the quantity. However, indirectly, the new 1900% higher share price could have impacted the market appetite for Titan Pharmaceuticals shares which in turn could have impacted Titan Pharmaceuticals's share price.

Titan Pharmaceuticals share price volatility

Over the last 12 months, Titan Pharmaceuticals's shares have ranged in value from as little as $3.9617 up to $14.8. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Titan Pharmaceuticals's is 1.083. This would suggest that Titan Pharmaceuticals's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).

Titan Pharmaceuticals overview

Titan Pharmaceuticals, Inc. , a pharmaceutical company, develops therapeutics for the treatment of chronic diseases in the United States and internationally. It develops products based on ProNeura, a proprietary long-term drug delivery platform. It also develops TP-2021 in combination with ProNeura technology for the treatment of chronic pruritus, a severe and debilitating condition defined as itching of the skin lasting longer than six weeks; and Nalmefene implant program for the prevention of opioid relapse following detoxification of patients suffering opioid use disorder. The company was founded in 1991 and is based in South San Francisco, California. .

Frequently asked questions

What percentage of Titan Pharmaceuticals is owned by insiders or institutions?
Currently 45.469% of Titan Pharmaceuticals shares are held by insiders and 3.521% by institutions. How many people work for Titan Pharmaceuticals?
Latest data suggests 4 work at Titan Pharmaceuticals. When does the fiscal year end for Titan Pharmaceuticals?
Titan Pharmaceuticals's fiscal year ends in December. Where is Titan Pharmaceuticals based?
Titan Pharmaceuticals's address is: 400 Oyster Point Boulevard, South San Francisco, CA, United States, 94080 What is Titan Pharmaceuticals's ISIN number?
Titan Pharmaceuticals's international securities identification number is: US8883146065 What is Titan Pharmaceuticals's CUSIP number?
Titan Pharmaceuticals's Committee on Uniform Securities Identification Procedures number is: 888314200